A Case Report of COVID-19 in Yemen: Detailed Clinical Observations
Khaled M. Alakhali *
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia, Thamar University College of Medicine and Health Sciences, Republic of Yemen and Taiz University College of Medicine and Health Sciences, Republic of Yemen.
Sultan M. Alshahrani
College of Pharmacy, King Khalid University, Abha, Saudi Arabia.
Yaser Mohammed Al- Worafi
University of Science and Technology of Fujairah, Fujairah, United Arab Emirates. and College of Pharmacy, University of Science and Technology, Sana’a, Yemen.
Lyna Irawati
Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
*Author to whom correspondence should be addressed.
Abstract
Coronavirus (COVID-19) is an infectious disease caused by a newly discovered coronavirus. We reported a 59-year-old Yemeni physician who was treated at home with complaints of COVID-19 symptoms. After receiving the treatment according to the COVID-19 guidelines established in Yemen, the patient made a slow recovery from 8 May 2020 to 28 May 2020. In conclusion, COVID-19 has a complicated clinical course and poor prognosis. Nevertheless, early aggressive treatment with an appropriate protocol could improve patient outcomes. However, in COVID-19, the thyroid gland plays a role in the immune system and medical professionals should consider assessing the thyroid gland in COVID-19 cases.
Keywords: Coronavirus, thyroid, gland, Yemen.